Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pilar M Samper Ots
Darbepoetin Versus Epoetin Alfa for the Correction of Anemia in Cancer Patients Receiving Radiotherapy or Chemoradiotherapy Treatment
Clinical medicine. Oncology
Related publications
Budget Impact Analysis of Darbepoetin Alfa Every 3 Weeks Versus Epoetin Alfa Every Week for Cancer Patients Receiving Chemotherapy From a Us Payer's Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Strategies for the Use of Epoetin Alfa in Breast Cancer Patients
Oncologist
Cancer Research
Medicine
Oncology
Darbepoetin Alpha in the Treatment of Cancer Chemotherapy-Induced Anemia
Therapeutics and Clinical Risk Management
Chemical Health
Pharmacology
Safety
Medicine
Toxicology
Safety Research
Pharmaceutics
Anemia Treatment With Q2W Darbepoetin Alfa in Patients With Chronic Kidney Disease Naïve to Erythropoiesis-Stimulating Agents
Current Medical Research and Opinion
Medicine
Beneficial Effect of High Dose Darbepoetin-Alfa in Peritoneal Dialysis Patients With Renal Anemia
Nihon Toseki Igakkai Zasshi
Postoperative Chemoradiotherapy Versus Radiotherapy Alone for Elderly Cervical Cancer Patients With Positive Margins, Lymph Nodes, or Parametrial Invasion
Journal of Gynecologic Oncology
Medicine
Gynecology
Oncology
Obstetrics
Practice Patterns and Outcomes of Chemoradiotherapy Versus Radiotherapy Alone for Older Patients With Nasopharyngeal Cancer
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Comparison of the Therapeutic Efficacy of Epoetin Beta and Epoetin Alfa in Maintenance Phase Hemodialysis Patients
Renal Failure
Medicine
Nephrology
Critical Care
Intensive Care Medicine
Epoetin Alfa in Platinum-Treated Ovarian Cancer Patients: Results of a Multinational, Multicentre, Randomised Trial
British Journal of Cancer
Cancer Research
Oncology
